Organisation paid for research Program year 2023 Source: CMS Open Payments

Best Quality Research

Neither a doctor nor a teaching hospital

Research payments

$126,564

9 payments

Through program year 2023, Best Quality Research is reported as receiving $126,564 in research payments, across 9 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$75,186	7
2022	Research	$42,798	1
2021	Research	$8,580	1

Breakdown

Who paid Research payments · program years 2021–2023

GlaxoSmithKline, LLC. $117,176 6 payments
Pfizer Inc. $9,388 3 payments

Studies the money was for Research payments · program years 2021–2023

A Phase 3, Open-Label, Randomized, Controlled, Multi Country Study to $117,176 6 payments
A Phase 12 Randomized Study to Evaluate the Safety Tolerability and Immunogenicity of A Modified Rna Vaccine Against Influenza in Healthy Individuals $8,580 1 payment
A Phase 3 Randomized Observerblinded Study to Evaluate the Safety Tolerability and Immunogenicity of A Combined Modified Rna Vaccine Candidate Against Covid19 and Influenza in Healthy Individuals $404 1 payment
A Phase 3 Randomized Observerblinded Study to Evaluate the Efficacy Safety Tolerability and Immunogenicity of A Modified Rna Vaccine Against Influenza Compared to Licensed Inactivated Influenza Vaccine in Healthy Adults 18 Years of Age Or Older $404 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.